Abiosciences logo — Discovery for Cure

Abiosciences

Discovery for Cure

Founded 2019 United States South San Francisco, United States 25 employees Series A Biotechnology

General Information

Company Name Abiosciences
Founded Year 2019
Location United States South San Francisco, United States +1
Founders / Decision Makers
Team member
Employees 25
Industries Biotechnology
Funding Stage Series A
Social

Get notified when Abiosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Abiosciences

Abiosciences is a biotechnology startup based in the United States, founded in 2018. The company's slogan "Discovery for Cure" reflects its dedication to leveraging single-cell genomics and bioinformatics to gain molecular insights into human diseases, with a focus on translating these insights into effective therapeutics and diagnostics. The company operates as a 10xGenomics Certified Lab, providing services to process samples to obtain scRNA datasets, and its Bioinformatics team is capable of processing multiomics data to facilitate research publication in leading journals. The last investment in Abiosciences was a Series A investment that took place on 26 May 2021. Noteworthy investors in this funding round include Green Pine Capital Partners, IDG Capital, Primavera Capital, and Sequoia Capital China. With a clear mission to alleviate human suffering from diseases such as cancer, Abiosciences aims to discover novel drug targets and therapeutic leads using advanced bioinformatics and single-cell technologies. The company firmly believes that insights from single-cell genomics research will significantly accelerate drug development and improve human health. Abiosciences extends an invitation to researchers worldwide to join in the quest to discover cures for a better future.

Taxonomy: Single-cell genomics, Bioinformatics, Therapeutics, Diagnostics, Drug development, Cancer research, Molecular insights, Multiomics data analysis, 10xGenomics Certified Lab, Research, Scientific discovery

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor
•••• ••••
26 May 2021
Series A •••••• 1
Investor
27 Jun 2019

Abiosciences Alternatives & Competitors

Abiosciences vs
Vizgen
Vizgen United States

Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial...

Series E
153 employees
Biotechnology, Health Care
Abiosciences vs

Pioneering the integration of human disease into pharmaceutical discovery, advancing biomedical rese...

Series C
Biotechnology, Health Care
Abiosciences vs
Relation
Relation United Kingdom

Discovering the relationships at the heart of biology to cure disease.

Unknown
130 employees
Biotechnology, Pharmaceutical

FAQ About Abiosciences

Discovery for Cure
Abiosciences was founded in 2019.
Abiosciences is headquartered in South San Francisco, United States.
Abiosciences operates in the following industries: Biotechnology.
Abiosciences has approximately 25 employees.
Abiosciences has completed 2 funding rounds. The latest funding stage is Series A.
Top alternatives and competitors to Abiosciences include Vizgen, Ardais Corporation, Relation, Biomage Ltd, Nygen Analytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Abiosciences and Vizgen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Abiosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy